Clinical Proteomics on the Way Towards Implementation: PROTEOMICS – Clinical Applications: Vol 13, No 2
![Obesity study on front cover of Proteomics - Clinical Applications - Institute for Bioengineering of Catalonia Obesity study on front cover of Proteomics - Clinical Applications - Institute for Bioengineering of Catalonia](http://ibecbarcelona.eu/wp-content/uploads/2018/02/sergiooller1.jpg)
Obesity study on front cover of Proteomics - Clinical Applications - Institute for Bioengineering of Catalonia
![Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms - eBioMedicine Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9d9de4c7-c46d-4393-9cb2-7fb4e2fdb76f/gr1_lrg.jpg)
Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms - eBioMedicine
![Frontiers | Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery | Medicine Frontiers | Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery | Medicine](https://www.frontiersin.org/files/Articles/747333/fmed-08-747333-HTML/image_m/fmed-08-747333-g001.jpg)
Frontiers | Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery | Medicine
PLOS ONE: Determination of Variation Parameters as a Crucial Step in Designing TMT-Based Clinical Proteomics Experiments
![Data Management of Sensitive Human Proteomics Data: Current Practices, Recommendations, and Perspectives for the Future - Molecular & Cellular Proteomics Data Management of Sensitive Human Proteomics Data: Current Practices, Recommendations, and Perspectives for the Future - Molecular & Cellular Proteomics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1b6e2175-6afe-4578-824d-b411240cff74/fx1_lrg.jpg)
Data Management of Sensitive Human Proteomics Data: Current Practices, Recommendations, and Perspectives for the Future - Molecular & Cellular Proteomics
PLOS ONE: Clinical Proteomics Identifies Urinary CD14 as a Potential Biomarker for Diagnosis of Stable Coronary Artery Disease
![Front Cover: Systematic Optimization of the iMALDI Workflow for the Robust and Straightforward Quantification of Signaling Proteins in Cancer Cells, PROTEOMICS - Clinical Applications - X-MOL Front Cover: Systematic Optimization of the iMALDI Workflow for the Robust and Straightforward Quantification of Signaling Proteins in Cancer Cells, PROTEOMICS - Clinical Applications - X-MOL](https://xpic.x-mol.com/20200915%2F10.1002_prca.202070051.jpg)